0001562180-23-008109.txt : 20231205
0001562180-23-008109.hdr.sgml : 20231205
20231205162214
ACCESSION NUMBER: 0001562180-23-008109
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quane Alessandrea C.
CENTRAL INDEX KEY: 0001667819
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40154
FILM NUMBER: 231466891
MAIL ADDRESS:
STREET 1: 175 WATER STREET
CITY: NEW YORK
STATE: NY
ZIP: 10038
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oscar Health, Inc.
CENTRAL INDEX KEY: 0001568651
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 403-3677
MAIL ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: Mulberry Health Inc.
DATE OF NAME CHANGE: 20130204
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-12-01
false
0001568651
Oscar Health, Inc.
OSCR
0001667819
Quane Alessandrea C.
75 VARICK STREET, 5TH FLOOR
NEW YORK
NY
10013
false
true
false
false
EVP, Chief Insurance Officer
false
Class A Common Stock
2023-12-01
4
M
false
7016.00
A
274633.00
D
Class A Common Stock
2023-12-01
4
M
false
34379.00
A
309012.00
D
Class A Common Stock
2023-12-04
4
S
false
22246.00
8.34
D
286766.00
D
Restricted Stock Units
2023-12-01
4
M
false
7016.00
0.00
D
Class A Common Stock
7016.00
49110.00
D
Restricted Stock Units
2023-12-01
4
M
false
34379.00
0.00
D
Class A Common Stock
34379.00
446935.00
D
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
/s/ Melissa Curtin, Attorney-in-Fact
2023-12-05